A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
- PMID: 18184961
- PMCID: PMC2295209
- DOI: 10.1056/NEJMoa073123
A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
Abstract
Hypoxia-inducible factor (HIF) alpha, which has three isoforms, is central to the continuous balancing of the supply and demand of oxygen throughout the body. HIF-alpha is a transcription factor that modulates a wide range of processes, including erythropoiesis, angiogenesis, and cellular metabolism. We describe a family with erythrocytosis and a mutation in the HIF2A gene, which encodes the HIF-2alpha protein. Our functional studies indicate that this mutation leads to stabilization of the HIF-2alpha protein and suggest that wild-type HIF-2alpha regulates erythropoietin production in adults.
2008 Massachusetts Medical Society
Figures
Comment in
-
The HIF2A gene in familial erythrocytosis.N Engl J Med. 2008 May 1;358(18):1965-6; author reply 1966-7. doi: 10.1056/NEJMc080274. N Engl J Med. 2008. PMID: 18450610 No abstract available.
-
The HIF2A gene in familial erythrocytosis.N Engl J Med. 2008 May 1;358(18):1966; author reply 1966-7. N Engl J Med. 2008. PMID: 18456917 No abstract available.
-
The HIF2A gene in familial erythrocytosis.N Engl J Med. 2008 May 1;358(18):1966; author reply 1966-7. N Engl J Med. 2008. PMID: 18456918 No abstract available.
References
-
- Bunn HF. New agents that stimulate erythropoiesis. Blood. 2007;109:868–73. - PubMed
-
- Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721–32. - PubMed
-
- Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004;5:343–54. - PubMed
-
- Kaelin WG. Proline hydroxylation and gene expression. Annu Rev Biochem. 2005;74:115–28. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases